Africa Corporate Wellness Market, by End User, 2018-2027
| Label | USD Million |
|---|---|
| 2018 | 3785.14532619392 USD Million |
| 2019 | 3862.3931899938 USD Million |
| 2020 | 3941.21754081 USD Million |
| 2021 | 4017.55101 USD Million |
| 2022 | 4112.13 USD Million |
| 2023 | 4457.137707 USD Million |
| 2024 | 4829.9029905621 USD Million |
| 2025 | 5232.23390967592 USD Million |
| 2026 | 5665.98610078806 USD Million |
| 2027 | 6133.05222169635 USD Million |
| 2028 | 6635.34919865328 USD Million |
| 2029 | 7178.34194140974 USD Million |
| 2030 | 7761.46258511693 USD Million |
| 2031 | 8390.91720076991 USD Million |
| 2032 | 9065.82664095184 USD Million |
Data Source: Wantstats Repository
Market Dynamics
The U.S. Psychedelic Drugs market is estimated to witness a substantial growth in the coming years, largely driven by a shift in attitudes towards the use of psychedelics in the treatment of mental health disorders. The market for psychedelic drugs in the USA is expected to witness rising demand from different sectors, such as the pharmaceutical industry, health care practitioners, and government agencies. Furthermore, the increasing acceptance of psychedelic drugs by society, as well as the growing number of clinical trials and studies, will foster the market growth during 2018-2032. Moreover, the rising incidence of mental health disorder in the US, along with the lack of effective treatment modalities, has played an important role in increasing the acceptance of psychedelic drugs. It is also estimated that the growing prominence of digital psychedelics, driven by the growing availability of the internet, and the acceptance of virtual reality (VR) and augmented reality (AR), will further drive the US psychedelic drugs market in the forecast period. In addition to this, the legalization of psychedelic drugs in certain US states has played an important role in the growth and acceptance of psychedelic drugs.
Moreover, the expanding therapeutic applications of psychedelic drugs in the USA, such as in the treatment of post traumatic stress disorder (PTSD), depression, and anxiety, and the rising awareness and demand for natural and alternative medicines, will be some of the major drivers of the US psychedelic drugs market in 2018 to 2032. Furthermore, the establishment of psychedelic and mental health research centers in the US is projected to play a pivotal role in the increasing acceptance and use of psychedelic drugs, and accelerating the growth of the US psychedelic drugs market in the near future. Additionally, the increasing number of clinical trials on psychedelic drugs, the introduction of numerous reform initiatives, and the increased investments in psychedelic research, will further drive the growth of the US psychedelic drugs market. However, the market growth may be hindered by certain factors such as, the stringent regulatory framework, and the high cost of psychedelic drugs production and research. Nevertheless, the rising awareness of the potential benefits of psychedelic drugs will play an important role in the growth of the US psychedelic drugs market.
Research Methodology
Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2023.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



